This activity is expired and is no longer available for CME credit.


EYE On Innovative Surgical Approaches That Extend Treatment Intervals in Neovascular Age-Related Macular Degeneration: PDS Implant Surgery

Author(s)/Faculty: Carl D. Regillo, MD, FACS
Release Date: 11/30/2020Expiration Date: 11/29/2021
Credit Type: CME / ABO MOCNumber of Credits: 0
Content Type: VideoProvider:
The integration of anti-vascular endothelial growth factor therapy into treatment regimens for the management of patients with neovascular age-related macular degeneration (nAMD) has demonstrated significant visual acuity gains. However, outcomes seen in pinnacle clinical studies are not always reflected in real-world clinical practice. Both the undertreatment of patients with nAMD and lack of patient compliance with dosing schedules due to treatment burden have been associated with less-than-optimal outcomes, identifying a need for alternative, durable therapy options. Sustained delivery devices and gene therapy are emerging options that have the potential to address treatment burden, but both require unique surgical approaches for optimal outcomes. In this CME activity, Dr. Carl Regillo discusses the surgical procedure for the placement of the Port Delivery System and reviews recent clinical trial data.